Cannabis Report
Home > Boards > US Listed > Medical - Drugs >

Spectrum Pharmaceutecals, Inc. (SPPI)

SPPI RSS Feed 		Add SPPI Price Alert      Hide Sticky   Hide Intro
Moderator: antihama
Search This Board: 
Last Post: 6/21/2018 7:40:31 AM - Followers: 80 - Board type: Free - Posts Today: 0

http://www.spectrumpharm.com/

- Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung Cancer (NSCLC) Presented at the 18th IASLC World Conference on Lung Cancer in Japan  - PR

http://investor.sppirx.com/releasedetail.cfm?ReleaseID=1044288
 

- 18th IASLC World Conference on Lung Cancer: Poziotinib Update - Conference Call 

https://edge.media-server.com/m6/p/4r5me9dd

.  

 

Cannabis Report
SPPI
Current Price
Volume:
Bid Ask Day's Range
SPPI Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPPI News: Statement of Changes in Beneficial Ownership (4) 06/19/2018 07:27:46 PM
SPPI News: Statement of Changes in Beneficial Ownership (4) 06/19/2018 07:19:57 PM
SPPI News: Statement of Changes in Beneficial Ownership (4) 06/19/2018 06:48:25 PM
SPPI News: Statement of Changes in Beneficial Ownership (4) 06/19/2018 06:39:11 PM
SPPI News: Statement of Changes in Beneficial Ownership (4) 06/19/2018 06:29:20 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2226   Regarding yesterday's 500,000 share buy, I think investors antihama 06/21/18 07:40:31 AM
#2225   SPPI now has Zacks Rank #2 (Buy) suggesting antihama 06/19/18 10:35:44 AM
#2224   Yesterday's stock trading was interesting because it wasn't. antihama 06/16/18 05:57:40 AM
#2223   Will MDAs basket trial be a multi-site trial antihama 06/13/18 01:34:19 PM
#2222   That's interesting. If there are any synergies of antihama 06/13/18 10:59:46 AM
#2221   Metformin in combination with Poziotinib might be interesting? klonk 06/13/18 06:59:47 AM
#2220   It's interesting to see Xalkori’s growth trajectory since antihama 06/12/18 10:41:57 PM
#2219   I can’t argue or disagree with your assessment.Still antihama 06/11/18 09:24:35 AM
#2218   Good write-up, antihama. Still a fair amount of EricHN 06/08/18 05:36:44 PM
#2217   New June Presentation on the Spectrum site. antihama 06/08/18 06:38:29 AM
#2216   Thoughts on the Jefferies HCC CC. antihama 06/08/18 06:35:49 AM
#2215   Commented on a SA article on Neulasta biosimilars. antihama 06/06/18 09:21:18 AM
#2214   Mylan's FULPHILA, a Neulata biosimilar received FDA approval. antihama 06/04/18 07:18:22 PM
#2213   I was just following my line of thinking antihama 05/24/18 06:50:39 AM
#2212   antihama, there was an data abstract at WCLC Ville 05/24/18 06:42:07 AM
#2211   Were 11 EGFR patients discussed in a WCLC antihama 05/23/18 08:25:31 PM
#2210   Impossible under ASCO rules. Just believe me. Ville 05/23/18 05:32:51 PM
#2209   That is why I didn't list it as antihama 05/23/18 06:53:43 AM
#2208   No. There are abstracts for data release and Ville 05/23/18 03:53:07 AM
#2207   Is Spectrum going to pull a nice surprise antihama 05/22/18 08:12:50 PM
#2206   NSCLC Exon mutations treated with checkpoint inhibitors have antihama 05/22/18 06:38:38 PM
#2205   SPPIs own P2 trial-"up to" 87 patient cohorts antihama 05/22/18 01:23:26 PM
#2204   Your responses are extremely helpful for a layman Matagordaville 05/22/18 11:04:52 AM
#2203   And I'd be remiss if I didn't mention antihama 05/22/18 10:42:52 AM
#2202   Figuring out the top catalyst for SPPI this antihama 05/21/18 05:39:09 PM
#2201   What would be the top catalysts or two Matagordaville 05/20/18 08:05:13 PM
#2200   I don't know if he will still be antihama 05/19/18 09:14:00 AM
#2199   He exercised 362,926 options and transferred them to EricHN 05/18/18 07:04:12 PM
#2198   I didn't have time to take a close antihama 05/18/18 12:27:56 PM
#2197   Speaking of Doc Raj and his Form 4 EricHN 05/18/18 09:52:37 AM
#2196   Pick The reason for share price jump yesterday antihama 05/18/18 07:15:34 AM
#2195   Who, what, where Huh? Up $2.49 or 13.96%. antihama 05/17/18 12:44:26 PM
#2194   CASI ownership by SPPI capped at 13.42%. antihama 05/17/18 08:14:20 AM
#2193   They corrected the PR regarding Rolontis patient number.CORRECTING antihama 05/17/18 07:14:55 AM
#2192   For now, yes. I am curious to know antihama 05/16/18 08:00:38 PM
#2191   Is he finished with selling? Ville 05/16/18 07:37:57 PM
#2190   Raj made a cool $17.7M from his 10b5 antihama 05/16/18 06:17:42 PM
#2189   I did a double take too but after antihama 05/16/18 05:43:33 PM
#2188   406 pts (ADVANCE) + 218 pts planned (RECOVER) Ville 05/16/18 05:41:46 PM
#2187   todays press release says 800pts in two phase Ville 05/16/18 05:34:39 PM
#2186   Merrill Lynch HCC;positive+good for newbies to listen to. antihama 05/16/18 03:07:28 PM
#2185   followed your suggestion the other day and bought antihama 05/12/18 08:30:55 AM
#2184   Had some time on my hands a couple antihama 05/11/18 10:41:25 AM
#2183   RE:Dr Heymach video on pozi exon 20 results antihama 05/10/18 07:27:27 AM
#2182   The Share Price Continuum to $6B Pozi sales. antihama 05/08/18 09:24:09 PM
#2181   Poziotinib exon 20 insertion potential is $6 Billion! antihama 05/08/18 11:43:51 AM
#2180   the market seems to be with you :) Ville 05/04/18 10:47:46 AM
#2179   earnings and CC isn't important. The other items Ville 05/04/18 07:02:00 AM
#2178   MASCC is about ADVANCE results. They only report Non-inferiority. Ville 05/04/18 06:59:37 AM
#2177   Correct me if I'm wrong...it seems like the EricHN 05/04/18 06:44:10 AM
PostSubject
© 2018 InvestorsHub.com, Inc.